Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Clinical trial NCT01174121 · RECRUITING
Trial details
- NCT number
- NCT01174121
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-26
- Primary completion
- 2028-12-27
- Enrollment
- 332
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.